Iron Indices and Vitamin D Receptor Polymorphisms in Hemodialysis Patients

Advances in Chronic Kidney Disease

Volumn 15, Issue 2, 2008, Pages 186-190

  Amato, Marcello ^a   Pacini, Stefania ^a   Aterini, Stefano ^a   Punzi, Tiziana ^a   Gulisano, Massimo ^a   Ruggiero, Marco ^a  

^a Prato Hospital   (Italy)

Author keywords

Chronic kidney disease; Gene polymorphism; Hemodialysis; Iron indices; Transferrin saturation; Vitamin D receptor

Indexed keywords

FERRITIN; IRON; RESTRICTION ENDONUCLEASE; RESTRICTION ENDONUCLEASE APAI; RESTRICTION ENDONUCLEASE BSMI; RESTRICTION ENDONUCLEASE FOKI; RESTRICTION ENDONUCLEASE TAQI; TRANSFERRIN; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN D DERIVATIVE; VITAMIN D RECEPTOR;

ADULT; AGED; ALLELE; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; HEMODIALYSIS; HUMAN; IRON BALANCE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; RECEPTOR GENE; RESTRICTION SITE; SURVIVAL TIME; TREATMENT RESPONSE; VITAMIN SUPPLEMENTATION;

EID: 40449117781     PISSN: 15485595     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ackd.2008.01.013     Document Type: Article

References (26)

1. D.E. Weiner H. Tighiouart M.G. Amin Chronic kidney disease as a risk factor for cardiovascular disease and all cause mortality: A pooled analysis of community-based studies J Am Soc Nephrol 15 2004 1307 1315
2. M.P. Marco L. Craver A. Betriu Higher impact of mineral metabolism on cardiovascular mortality in a European hemodialysis population Kidney Int 63 2003 S111 S114 (suppl 85)
3. F. Locatelli S. Andrulli B. Memoli Nutritional-inflammation status and resistance to erythropoietin therapy in hemodialysis patients Nephrol Dial Transplant 21 2006 991 998
4. M.P. Marco L. Craver A. Betriu Influence of vitamin D receptor gene polymorphisms on mortality risk in hemodialysis patients Am J Kidney Dis 4 2001 965 974
5. Y.C. Li G. Qiao M. Uskokovic Vitamin D: A negative endocrine regulator of the renin-angiotensin system and blood pressure J Steroid Biochem Mol Biol 89 2004 387 392
6. S. Aterini M. Salvadori E. Ippolito The role of vitamin D receptor gene alleles in the secondary hyperparathyroidism of hemodialysis patients J Nephrol 9 1996 201 206 Available at: http://www.sin-italy.org/vecchiosito/jnonline/vol9n4/201.html Accessed February 21, 2008
7. K.E. Watson M.L. Abrolat L.L. Malone Active serum vitamin D levels are inversely correlated with coronary calcification Circulation 108 2003 2041 2048
8. B.J. Frankel A.M. Heldt G.M. Grodsksy Vitamin D deficiency inhibits pancreatic secretion of insulin Science 209 1980 823 825
9. S. Ertürk S. Kutlay H.G. Karabulut The impact of vitamin D receptor genotype on the management of anemia in hemodialysis patients Am J Kidney Dis 40 2002 816 823
10. A.G. Uitterlinden Y. Fang J.B. Van Meurs Genetics and biology of vitamin D receptor polymorphisms Gene 338 2004 143 156
11. E. Vigo Gago C. Cadarso-Suarez R. Perez-Fernandez Association between vitamin D receptor FokI. Polymorphism and serum parathyroid hormone level in patients with chronic renal failure J Endocrinol Invest 28 2005 117 121
12. L.B. Pupim K. Caglar R.M. Hakim Uremic malnutrition is a predictor of death independent of inflammatory status Kidney Int 66 2004 2054 2060
13. D. Coyne Iron indices: What do they really mean? Kidney Int 69 2006 S4 S8 (suppl 101)
14. C. Gross A.V. Krishnan P.J. Malloy The vitamin D receptor gene start codon polymorphism: A functional analysis of FokI variants J Bone Miner Res 13 1998 1691 1699
15. H. Arai K.I. Miyamoto Y. Taketani A vitamin D receptor gene polymorphism in the translation initiation codon: Effect on protein activity and relation to bone mineral density in Japanese women J Bone Miner Res 12 1997 915 921
16. E. Kulah A. Dursun S. Acikgoz The relationship of target organ damage and 24-hour ambulatory blood pressure monitoring with vitamin D receptor gene fok-I polymorphism in essential hypertension Kidney Blood Press Res 29 2006 344 350
17. A. Levin Y.C. Li Vitamin D and its analogues: Do they protect against cardiovascular disease in patients with kidney disease? Kidney Int 68 2005 1973 1981
18. D.L. Andress Vitamin D in chronic kidney disease: A systemic role for selective vitamin D receptor activation Kidney Int 69 2006 33 43
19. M. Teng M. Wolf E. Lowrie Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy N Engl J Med 349 2003 446 456
20. T. Shoji K. Shinohara E. Kimoto Lower risk for cardiovascular mortality in oral 1 alpha-hydroxy vitamin D-3 users in a haemodialysis population Nephrol Dial Transplant 19 2004 179 184
21. M. Teng M. Wolf M.N. Ofsthun Activated injectable vitamin D and hemodialysis survival: A historical cohort study J Am Soc Nephrol 16 2005 1115 1125
22. R. Agarwal M. Acharya J. Tian Antiproteinuric effect of oral paricalcitol in chronic kidney disease Kidney Int 68 2005 2823 2828
23. K. Makibayashi M. Tatematsu M. Hirata A vitamin D analog ameliorates glomerular injury on rat glomerulonephritis Am J Pathol 158 2001 1733 1741
24. Z. Zhang W. Yuan L. Sun 1,25-Dihydroxyvitamin D-3 targeting of NF-kappa B suppresses high glucose-induced MCP-1 expression in mesangial cells Kidney Int 72 2007 193 201
25. Z. Zhang L. Sun Y. Wang Renoprotective role of the vitamin D receptor in diabetic nephropathy Kidney Int 73 2008 163 171
26. A. Kuhlmann C.S. Haas M.L. Gross 1,25-Dihydroxyvitamin D-3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat Am J Physiol Renal Physiol 286 2004 F526 F533